| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | Dec 1, 2025 | Pasithea Therapeutics Corp. | Director | Buy | 95.0 | +133,333 | 200.93% | ✗ | $100K |
| Dec 19, 2023 | Dec 19, 2023 | BioAtla, Inc. | Director | Buy | 91.3 | +20,000 | 108.35% | ✗ | $41K |
| Jun 2, 2023 | Jun 6, 2023 | Pasithea Therapeutics Corp. | Director | Buy | 78.8 | +30,000 | 2.31% | ✗ | $12.9K |
| Jun 1, 2023 | Jun 2, 2023 | ETHZilla Corp | Director | Buy | 91.3 | +18,000 | 59.74% | ✗ | $22.1K |
| Dec 9, 2021 | Dec 10, 2021 | ETHZilla Corp | Director | Buy | 68.8 | +5,000 | 0.84% | ✗ | $21.4K |
| Nov 2, 2021 | Nov 3, 2021 | BioAtla, Inc. | Director | Sell | 45.0 | -450 | -2.38% | ✓ | $13.5K |
| Sep 15, 2021 | Sep 17, 2021 | BioAtla, Inc. | Director | Sell | 45.0 | -450 | -2.32% | ✓ | $16.6K |
| Aug 16, 2021 | Aug 18, 2021 | BioAtla, Inc. | Director | Sell | 45.0 | -450 | -2.27% | ✓ | $18.3K |
| Jul 15, 2021 | Jul 19, 2021 | BioAtla, Inc. | Director | Sell | 45.0 | -450 | -2.22% | ✓ | $17.2K |